Apigenin is a plant-derived flavonoid concentrated in chamomile, parsley, and celery. Interest in supplementing it has grown considerably, with doses of 25 mg and 50 mg appearing frequently in wellness discussions. Before deciding on a number, it is worth understanding what the research actually supports, and where significant gaps remain.
This guide examines the available human and laboratory evidence around apigenin dosage, absorption, and the pharmacokinetic factors that affect how much reaches your tissues. These statements have not been evaluated by the FDA; apigenin is not intended to diagnose, treat, cure, or prevent any disease. This is informational, not medical advice.
Key Takeaways
- No human RCT has directly compared 25 mg and 50 mg apigenin; neither dose has been established as clinically superior by controlled research.
- Bioavailability is highly variable: gut microbiome, individual metabolism, and formulation all affect how much apigenin reaches circulation from any given dose [1][2].
- Enhanced delivery formats such as phospholipid phytosomes improved bioavailability in rats, but no human formulation data exist, so a lower dose in an enhanced format cannot be assumed to match a higher standard dose [17][7][6].
- In lab tests apigenin inhibits CYP1A2, CYP2C9, and CYP3A4 and affects drug efflux transporters; no human interaction study is in the evidence, but those on warfarin, statins, or benzodiazepines should still consult a physician before supplementing [12][13][14][15][16].
- Starting at 25 mg is a reasonable conservative approach for new users; 50 mg remains within the common supplement range but is convention-based rather than trial-validated.
Why Dosage Is More Complex Than a Single Number
Apigenin’s dose-response relationship in humans is not yet well characterized by large clinical trials. Much of what informs supplement dosing comes from dietary intake studies, in vitro research, and a limited number of human pharmacokinetic investigations. The popular figures of 25 mg and 50 mg are not derived from head-to-head randomized trials proving one superior to the other: they have largely been established through convention and product formulation rather than formal dose-finding studies.
A key variable is bioavailability. Apigenin is poorly soluble in water, meaning a meaningful portion of an oral dose can pass through the gastrointestinal tract without being absorbed efficiently. The form you take (isolated aglycone in a capsule, a glycoside delivered through food, or a purpose-designed enhanced delivery system) can shift how much actually enters circulation. This means that the number on the label and the amount reaching target tissues are not the same figure.
What Human Bioavailability Data Shows
One study examined the bioavailability of apigenin from apiin-rich parsley in healthy human volunteers. Apigenin was detectable in plasma after parsley consumption, but absorption was variable across participants. The glycoside form present in most plant foods requires gut microbial activity to cleave the sugar before the free aglycone can be absorbed [1]. This variability has a practical implication: the same nominal dose may produce quite different circulating levels depending on individual gut microbiome composition.
Research note: In every volunteer plasma apigenin rose after parsley and fell below the detection limit of 2.3 nmol/l within 28 hours, so a single dose is cleared within about a day [1].
A separate line of research explored whether formulation could address this absorption problem. An apigenin-phospholipid phytosome was developed by binding apigenin to a phospholipid carrier to improve aqueous dispersion. This formulation was associated with improved solubility and in vivo bioavailability compared to unformulated apigenin [2]. The implication for dosing is limited: the phytosome result comes from rats, the review that summarises it reports no human data, and its comparator is unclear, so no human evidence shows a lower dose in an enhanced format matches a higher standard dose [17].
How Apigenin Is Metabolized and Cleared
After absorption, apigenin undergoes phase II metabolism primarily through sulfation and glucuronidation, producing water-soluble conjugates that can be excreted. Research on the efflux of apigenin sulfates found that the multidrug resistance-associated protein MRP4 (ABCC4) plays a measurable role in their cellular export [3]. This means transporter expression can influence how much active compound is retained intracellularly at any given time, independent of the dose ingested.
This metabolic picture complicates dose selection because bioactive tissue exposure depends not only on the dose swallowed but on individual differences in sulfotransferase enzyme activity, gut microbiome robustness, and cellular transporter expression. These factors are not visible on a supplement label and are not accounted for by any standard dosing recommendation. They reinforce why the 25 mg versus 50 mg debate cannot be settled by citing a single number from the literature.
The 25 mg vs 50 mg Debate: What the Evidence Actually Supports
There is currently no published human randomized controlled trial directly comparing 25 mg apigenin to 50 mg apigenin for any endpoint: sleep latency, anxiety scores, NAD+ biomarkers, or otherwise. The 50 mg figure has been popularized largely through podcast and influencer culture, not because it was derived from a formal dose-finding study. That does not make 50 mg unsafe, but it does mean the specific number does not carry clinical authority from controlled research.
What the collective evidence suggests is a practical starting range rather than a validated optimal point. In 11 healthy adults who ate blanched parsley, apigenin appeared in plasma with wide variation between people, and pure apigenin given to healthy men was poorly absorbed. Whether enhanced delivery formats shift the effective human dose range has not been tested [1][4][17]. For individuals new to apigenin supplementation, 25 mg represents a conservative starting point that limits exposure while allowing personal tolerance to be established over several weeks. Those who have used 25 mg without issue and want to explore a higher common dose might consider 50 mg, acknowledging that this choice is based on convention rather than a demonstrated pharmacological threshold.
The only human trial of a 50 mg dose in the evidence tested an evening blend of magnesium L-threonate, L-theanine and 50 mg of apigenin in 103 healthy adults. The evening blend did not produce significant improvements across outcome measures, and because it was a combination it cannot show what apigenin alone does at that dose [11].
Food Sources vs Supplements: A Dosing Perspective
Apigenin is present in chamomile flowers, fresh parsley, celery, and dried herbs. A cup of chamomile tea provides apigenin glycosides, and fresh parsley can deliver a meaningful amount per serving, though the aglycone content available after gut bacterial conversion is highly variable between individuals [1]. Consistently reaching 25 to 50 mg per day through food sources alone would require substantial daily servings of these specific foods.
Food sources deliver apigenin alongside other polyphenols, dietary fiber, and food matrix components that may influence absorption and metabolism in ways that are not yet fully characterized. Isolated supplements, by contrast, deliver a fixed dose without these cofactors. Neither approach is inherently superior to the other. Individuals who want consistent, measurable dosing over a defined period are better served by a standardized supplement product. Those seeking a gentler, food-integrated approach can incorporate daily chamomile tea and parsley with realistic expectations about the dose delivered.
Drug Interactions and Cautions That Should Inform Dose Decisions
In lab tests, apigenin inhibits the cytochrome P450 enzymes CYP1A2, CYP2C9, and CYP3A4. These enzymes metabolize a broad range of medications including warfarin, certain statins, and benzodiazepines. If the same inhibition happened in people, blood levels of co-administered drugs could rise, but no clinical apigenin interaction study is in the evidence [12][13][14][15][18]. A cell study found that apigenin sulfate metabolites are exported by the efflux transporter MRP4 [3]. Anyone taking CYP-metabolized medications should consult a physician before adding apigenin supplementally at any dose.
Apigenin has not been shown to promote sleep in people, and its GABA-A action is unsettled: it bound the benzodiazepine site in rat brain assays, but in cell work it inhibited GABA activation on its own without acting through that site. Stacking it with other sedative agents (melatonin, alcohol, prescription sleep medications, or anxiolytics) is still a reasonable precaution [8][9][10][11]. This caution applies at 25 mg and at 50 mg equally; a lower dose is not automatically interaction-free. Timing, total sedative load, and individual sensitivity all matter more than the precise milligram figure.
🛒 Where to Buy Apigenin
- Momentous Apigenin
capsules, 50 mg per capsule, 60 count: NSF Certified for Sport, meaning batch testing against a banned-substance list and verification that the label matches the contents - Vitamatic Apigenin 50mg
capsules, 50 mg per capsule, 120 vegetarian capsules: The lowest cost per dose on this list, and a vegetarian capsule if gelatin is a constraint; the listing states no third-party certification - Nutricost Apigenin 50mg
capsules, 50 mg per capsule, 180 count: Non-GMO, gluten free and vegan, and the best cost per capsule among the larger bottles here - Swanson Apigenin 50mg
capsules, 50 mg per capsule, 90 count: A long-established supplement brand, in the smaller 90-count bottle; the listing frames it around sleep and relaxation
As an Amazon Associate we earn from qualifying purchases. Apigenin products differ mainly in what else is in the capsule (some are plain apigenin, others blend it with L-theanine, valerian root or magnesium) so check the label for the actual apigenin dose per serving, and prefer products that publish third-party testing.
Understanding Apigenin Bioavailability and Metabolism
Before discussing specific dosages, it is crucial to understand how apigenin is absorbed and processed by the body. Apigenin, like many flavonoids, has relatively low oral bioavailability. This means only a small fraction of the ingested compound reaches systemic circulation in its active form. In healthy men, apigenin taken as the free aglycone was poorly absorbed, with urinary metabolites equivalent to roughly 0.5 percent of intake, whereas the same compound delivered as its natural glycosides in parsley reached about 11 percent and in chamomile tea about 34 percent[4]. Those absorption limits, and apigenin’s interactions with drug metabolism, have been reviewed in detail[5].
Its metabolism primarily occurs in the gut and liver, involving glucuronidation and sulfation, which can reduce its biological activity. Research is ongoing into novel delivery methods and formulations designed to enhance apigenin’s absorption and efficacy, such as micronized forms or phospholipid complexes. In rats, apigenin nanocrystals reached a peak plasma concentration about 3.6 times that of coarse powder[6], and a carbon nanopowder solid dispersion raised total exposure roughly 1.8-fold[7]. Those are animal pharmacokinetic results; no human trial has shown that a consumer formulation of apigenin produces a clinical benefit.
A Note on the Evidence
The human evidence base for specific apigenin supplement doses is preliminary; guidance is extrapolated from dietary bioavailability studies and in vitro models rather than large clinical trials, and individual responses will vary. Anyone on warfarin, statins, benzodiazepines, or other medications metabolized by CYP1A2, CYP2C9, or CYP3A4 must consult a physician before use, and combining apigenin with any sedative agent, including melatonin or alcohol, warrants caution.
Frequently Asked Questions
Is 50 mg of apigenin safe for daily use?
For healthy adults not taking interacting medications, 50 mg is within the range most supplement products offer. No human trial has tested pure apigenin for safety, though adverse events in chamomile extract trials did not differ significantly from placebo [19][20][21]. However, apigenin inhibits multiple CYP enzymes that metabolize common prescription drugs, so anyone on relevant medications should seek physician guidance before supplementing at any dose. Long-term safety data in humans is limited.
Does the formulation of apigenin affect how much I actually absorb?
Possibly, but the data are from animals. Research on a phospholipid phytosome formulation found improved solubility and in vivo bioavailability compared to the unformulated compound in rats [2], and no human formulation data exist, so an enhanced product at 25 mg cannot be assumed to match a standard powder at a higher stated dose [17].
How much apigenin is in chamomile tea compared to a supplement?
Chamomile flowers contain apigenin glycosides, but the milligram amount per brewed cup varies considerably by brand, water temperature, and steep time. Studies on parsley found that apigenin from food is absorbed but with meaningful individual variability due to the gut microbial conversion step required for the glycoside form [1]. A standardized supplement provides more predictable dosing than tea for those wanting consistency.
Can I take apigenin alongside melatonin?
Both are used for sleep, but apigenin has not been shown to promote sleep onset in people, and combining them could in theory produce additive sedation [11][22]. There is no established safe stacking dose from clinical research. This is a practical caution rather than an absolute contraindication, but individuals sensitive to sedatives or those combining multiple sleep aids should be conservative and consult a healthcare provider before using both regularly.
Why does apigenin interact with so many drugs?
In lab tests, apigenin inhibits CYP1A2, CYP2C9, and CYP3A4, three of the most important drug-metabolizing enzymes in the liver. A cell study also shows that apigenin sulfate metabolites are substrates of the efflux transporter MRP4 (ABCC4) [3]. These are enzyme-assay results at micromolar concentrations, not measured interactions in people, so whether a 25 mg dose matters clinically is unknown [12][13][14][15][18].
Should I start at 25 mg or 50 mg if I am new to apigenin?
Starting at 25 mg is the more conservative approach and is appropriate for most new users, particularly given the variability in individual bioavailability [1] and the absence of clinical dose-finding trials. If 25 mg is well tolerated after several weeks and you have confirmed you are not on interacting medications, 50 mg is a reasonable next step, though you should not expect a proportional increase in effect given the absorption variables involved.
References
- Meyer H et al. Bioavailability of apigenin from apiin-rich parsley in humans. Annals of nutrition & metabolism (2006). PMID 16407641
- Telange DR et al. Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017). PMID 27939619
- Li W et al. Efflux transport of chrysin and apigenin sulfates in HEK293 cells overexpressing SULT1A3: The role of multidrug resistance-associated protein 4 (MRP4/ABCC4). Biochemical pharmacology (2015). PMID 26291395
- Borges G et al. Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. Free Radic Biol Med (2022). PMID 35452808
- Tang D et al. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol (2017). PMID 27766890
- Zhang J et al. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci (2013). PMID 23305994
- Ding SM et al. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int J Nanomedicine (2014). PMID 24872695
- Haydée Viola et al. Apigenin, a Component ofMatricaria recutitaFlowers, is a Central Benzodiazepine Receptors-Ligand with Anxiolytic Effects. Planta Medica (1995). PMID 7617761
- Campbell EL et al. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochemical pharmacology (2004). PMID 15451406
- Goutman JD et al. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. European journal of pharmacology (2003). PMID 12586201
- Mastrofini GF et al. Modulating stress and sleep through a multi-compound dietary supplement: a randomized, double-blind, placebo-controlled trial. Journal of the International Society of Sports Nutrition (2026). PMID 42829807
- Wang Z et al. Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro. Pharmacology (2016). PMID 27287328
- Si D et al. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug metabolism and disposition: the biological fate of chemicals (2009). PMID 19074529
- Shimada H et al. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein. Journal of biochemical and molecular toxicology (2010). PMID 20806393
- Kondža M et al. Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids. Molecules (Basel, Switzerland) (2021). PMID 34069400
- Roberto Cannataro et al. Polyphenols in the Mediterranean Diet: From Dietary Sources to microRNA Modulation. Antioxidants (2021). PMID 33672251
- Valentina Fiftianingrum et al. Advancements in Nanomedicine Platforms and Solid-State Engineering for Enhancing the Solubility of Apigenin: A Narrative Review. International Journal of Nanomedicine (2026). PMID 42910236
- Fei Lin et al. Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450. Frontiers in Pharmacology (2023). PMID 36874034
- Amsterdam JD et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of clinical psychopharmacology (2009). PMID 19593179
- Conti F Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. Nutrition reviews (2026). PMID 40418260
- Zick SM et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC complementary and alternative medicine (2011). PMID 21939549
- Atena Pasban et al. The Effect of Chamomile on Common Psychological Disorders Including Depression, Anxiety, Stress and Sleep Disorders: A Narrative Review. Iranian Journal of Psychiatry and Behavioral Sciences (2025). doi:10.5812/ijpbs-157547
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
